With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: ...

Innorna, a clinical-stage biotechnology company revolutionizing mRNA therapeutics with its innovative lipid nanoparticle (LNP ...

One of the House's foremost experts on the nation's health systems breaks down the terrifying pace at which Kennedy is ...